BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38855155)

  • 1. Exosomal microRNAs in hepatocellular carcinoma, expanding research field.
    Zheng BH; Ni XJ; Liu HB
    World J Gastroenterol; 2024 May; 30(20):2618-2620. PubMed ID: 38855155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
    Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
    World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
    Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
    Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
    Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
    Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of exosomal circular RNAs as microRNA sponges and potential targeting for suppressing hepatocellular carcinoma growth and progression.
    Papadopoulos N; Trifylli EM
    World J Gastroenterol; 2024 Mar; 30(9):994-998. PubMed ID: 38577187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
    Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
    RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
    Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
    Li S; Yao J; Xie M; Liu Y; Zheng M
    J Hematol Oncol; 2018 Apr; 11(1):54. PubMed ID: 29642941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo.
    Suda T
    World J Gastroenterol; 2024 May; 30(17):2369-2370. PubMed ID: 38813056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-transmitted long non-coding RNA
    Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
    Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncovering essential anesthetics-induced exosomal miRNAs related to hepatocellular carcinoma progression: a bioinformatic investigation.
    Huang N; Fang J; Du F; Zhou J; Li Y; Zhang X
    BMC Med Genomics; 2024 Jun; 17(1):154. PubMed ID: 38840234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
    Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
    Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression.
    Chen W; Quan Y; Fan S; Wang H; Liang J; Huang L; Chen L; Liu Q; He P; Ye Y
    Cancer Lett; 2020 Apr; 475():119-128. PubMed ID: 32014458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
    Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
    Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373.
    Muhammad Yusuf AN; Raja Ali RA; Muhammad Nawawi KN; Mokhtar NM
    Malays J Pathol; 2020 Dec; 42(3):377-384. PubMed ID: 33361718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
    Wu MN; Sun JY; Yao M; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
    Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
    Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.